mhurhangee/ep-ind-claims huggingface dataset:
A transformer system for a direct current converter system, comprising a plurality of windings (4a, 4b, 4c, 5a, 5b, 5c) for three electrical phases (3a, 3b, 3c), the windings (4a, 4b, 4c, 5a, 5b, 5c) being electrically connected to provide a 15° phase shift, and comprising at least three separate tanks (6a, 6b, 6c), wherein the windings (4a, 4b, 4c, 5a, 5b, 5c) associated to different electrical phases (3a, 3b, 3c) are located in different ones of the separate tanks (6a, 6b, 6c), comprising for each electrical phase (3a, 3b, 3c) at least one first winding (4a, 4b, 4c) and at least one second winding (5a, 5b, 5c) electrically connected to each other, wherein the first winding (4a, 4b, 4c) and the second winding (5a, 5b, 5c) for the same electrical phase (3a, 3b, 3c) are located in the same tank (6a, 6b, 6c), wherein the first winding (4a, 4b, 4c) and the second winding (5a, 5b, 5c) for the same electrical phase (3a, 3b, 3c) are located on a common core, wherein the windings (4a, 4b, 4c, 5a, 5b, 5c) are connected in an extended-side delta connection, where the first windings (4a, 4b, 4c) are connected to each other in a delta configuration and the second windings (5a, 5b, 5c) are the extended windings and are connected between the associated first windings (4a, 4b, 4c) and the electrical phases (3a, 3b, 3c). comprising a plurality of windings (4a, 4b, 4c, 5a, 5b, 5c) for three electrical phases (3a, 3b, 3c), the windings (4a, 4b, 4c, 5a, 5b, 5c) being electrically connected to provide a 15° phase shift, and comprising at least three separate tanks (6a, 6b, 6c), wherein the windings (4a, 4b, 4c, 5a, 5b, 5c) associated to different electrical phases (3a, 3b, 3c) are located in different ones of the separate tanks (6a, 6b, 6c), comprising for each electrical phase (3a, 3b, 3c) at least one first winding (4a, 4b, 4c) and at least one second winding (5a, 5b, 5c) electrically connected to each other, wherein the first winding (4a, 4b, 4c) and the second winding (5a, 5b, 5c) for the same electrical phase (3a, 3b, 3c) are located in the same tank (6a, 6b, 6c), wherein the first winding (4a, 4b, 4c) and the second winding (5a, 5b, 5c) for the same electrical phase (3a, 3b, 3c) are located on a common core, wherein the windings (4a, 4b, 4c, 5a, 5b, 5c) are connected in an extended-side delta connection, where the first windings (4a, 4b, 4c) are connected to each other in a delta configuration and the second windings (5a, 5b, 5c) are the extended windings and are connected between the associated first windings (4a, 4b, 4c) and the electrical phases (3a, 3b, 3c).
A positive electrode active material for a potassium secondary battery, which is a crystalline material comprising K, a transition metal, P, and O, the crystalline material having a composition of Formula 1, [Formula 1] (K 1-a M1 a)(M2 1-b M3 b)P c O d wherein, M1 is one or more among alkali metal elements other than K, M2 and M3 are one or more among transition metal elements, and 0≤a≤0.2, 0≤b≤0.7, 1.8≤c≤2.2, and 6.8≤d≤7.2, characterized in that the crystalline material comprising as a main phase, a phase showing a diffraction peak having a relative intensity of 5% or more in a range of Bragg angles (2θ) of an X-ray diffraction pattern of 14.7° to 15.7°, 22.1° to 23.1°, 25.5° to 26.5°, and 29.7° to 30.8° when a relative intensity of a diffraction peak having the strongest intensity is taken as 100% in the powder X-ray diffraction pattern of the material, and in the crystalline material, a phase transition to a monoclinic crystal structure and a triclinic crystal structure is dynamically performed in a charge and discharge process. the crystalline material comprising as a main phase, a phase showing a diffraction peak having a relative intensity of 5% or more in a range of Bragg angles (2θ) of an X-ray diffraction pattern of 14.7° to 15.7°, 22.1° to 23.1°, 25.5° to 26.5°, and 29.7° to 30.8° when a relative intensity of a diffraction peak having the strongest intensity is taken as 100% in the powder X-ray diffraction pattern of the material, and in the crystalline material, a phase transition to a monoclinic crystal structure and a triclinic crystal structure is dynamically performed in a charge and discharge process.
An aorta treatment device (100, 200) comprising: a branched artificial blood vessel portion including a main tube and at least one side tube (11, 12, 13, 14) that branches off from the main tube; a stent graft portion (20, 25) coupled to a distal side of the branched artificial blood vessel portion; and a cuff portion that is formed so as to extend from a distal end of the branched artificial blood vessel portion toward the distal side, that is evertable so as to extend from the distal end of the branched artificial blood vessel portion toward a proximal side, and that has a cylindrical shape or a skirt-like shape, wherein the cuff portion has a skirt-like shape such that a length thereof is 5 to 30 mm and a ratio of an inside diameter of an open end to an inside diameter of a base end is 1.05 to 1.3. a branched artificial blood vessel portion including a main tube and at least one side tube (11, 12, 13, 14) that branches off from the main tube; a stent graft portion (20, 25) coupled to a distal side of the branched artificial blood vessel portion; and a cuff portion that is formed so as to extend from a distal end of the branched artificial blood vessel portion toward the distal side, that is evertable so as to extend from the distal end of the branched artificial blood vessel portion toward a proximal side, and that has a cylindrical shape or a skirt-like shape, wherein the cuff portion has a skirt-like shape such that a length thereof is 5 to 30 mm and a ratio of an inside diameter of an open end to an inside diameter of a base end is 1.05 to 1.3.
A salt which is N-(4-(4-Amino-7-(1-isobutyrylpiperidin-4-yl)pyrrolo[1,2-f][1,2,4]triazin-5-yl)phenyl)-1-isopropyl-2,4-dioxo-3-(pyridin-2-yl)-1,2,3,4-tetrahydropyrimidine-5-carboxamide maleic acid salt.
A medical lighting device, especially for an operating theater, including a lighting head, comprising a body, wherein at least one light source is mounted, which is adapted to generate a light beam, with a handle extending along an axis, mounted on the body and rotatable relative to the body about the axis of said handle, control means (16, 12) located in the body and adapted to control a lighting parameter, means (18a, 18b, 26a, 26b) for detecting the angular position of the handle, with the detection means including at least one first portion (26a, 26b) rotatably coupled relative to the handle and at least one second portion (18a, 18b) rotatably coupled relative to the body and which is adapted to supply the control means (16, 12) with a signal which is representative of the angular position of the handle relative to the body, with the second portion (18a, 18b) being adapted to detect the angular position of the first portion (26a, 26b) with no contact, or vice versa, and the detection means including at least one first and one second optical forks (18a, 18b) adapted to detect two different angular positions of the handle, with each optical fork (18a, 18b) comprising a light emitter and a receiver positioned opposite the emitter and which is adapted to detect a light signal emitted by said emitter, with the detection means further including first and second lugs which form obstacles (26a, 26b), with the first lug being adapted to be inserted between the emitter and the receiver of the first optical fork in a first angular position of the handle, with the second lug being adapted to be inserted between the emitter and the receiver of the second optical fork in a second angular position of the handle.
A topical personal care composition for improving cellular energy efficiency, comprising: (a) from 0.001 to 10% preferably, from 0.01 to 6%, and most preferably, from 0.05 to 3.5%, by weight, of niacinamide compound of Structural Formula 3 from 0.001 to 10%, preferably from 0.01 to 6%, by weight, of a cooperative skin benefit agent selected from the group consisting of compound of General Structural Formula I compound of General Structural Formula II wherein R 1 = methyl, ethyl, propyl, and X - = counterions to form a salt; wherein R 2 = methyl, ethyl, propyl, hydroxymethyl, 2-hydroxyethyl and R 3 = ethyl, isopropyl, or physiologically suitable counterion; and mixtures thereof; (b) an optional additional skin benefit agent; and (c) a cosmetically acceptable carrier; wherein said cooperative skin benefit agent contains N-acetylmethionine of Structural Formula 2: (a) from 0.001 to 10% preferably, from 0.01 to 6%, and most preferably, from 0.05 to 3.5%, by weight, of niacinamide compound of Structural Formula 3 from 0.001 to 10%, preferably from 0.01 to 6%, by weight, of a cooperative skin benefit agent selected from the group consisting of compound of General Structural Formula I compound of General Structural Formula II wherein R 1 = methyl, ethyl, propyl, and X - = counterions to form a salt; wherein R 2 = methyl, ethyl, propyl, hydroxymethyl, 2-hydroxyethyl and R 3 = ethyl, isopropyl, or physiologically suitable counterion; and mixtures thereof; (b) an optional additional skin benefit agent; and (c) a cosmetically acceptable carrier; wherein said cooperative skin benefit agent contains N-acetylmethionine of Structural Formula 2:
A method for reducing continuous-wakeup delay of a Bluetooth loudspeaker, the method comprising the following steps: resetting a wakeup flag bit to wait for a next wakeup, when a stop-recording instruction sent by a terminal equipment through a Bluetooth serial port communication protocol is received, after resetting the wakeup flag bit, playing voice data when the voice data as fed back by the terminal equipment is received, wherein the voice data is a response data of voice data collected when the Bluetooth loudspeaker is previously awakened; and executing a wakeup-interruption operation when a preset wakeup keyword is received by the Bluetooth loudspeaker. resetting a wakeup flag bit to wait for a next wakeup, when a stop-recording instruction sent by a terminal equipment through a Bluetooth serial port communication protocol is received, after resetting the wakeup flag bit, playing voice data when the voice data as fed back by the terminal equipment is received, wherein the voice data is a response data of voice data collected when the Bluetooth loudspeaker is previously awakened; and executing a wakeup-interruption operation when a preset wakeup keyword is received by the Bluetooth loudspeaker.
A treated surface of a device for implantation or for application as a wound dressing, the treated surface comprising a plurality of surface-oxidised in particular plasma-activated hydrophilic cell-adhesive areas having the ability to reduce fibrous reaction, said plurality of surface-oxidised in particular plasma-activated hydrophilic cell-adhesive areas being in the form of an array of islets of activation, each islet of activation having a length which is less than 6μm, a width which is less than 2 μm and wherein the distance between islets is from 2 μm to 6 μm, the islets of activation being surrounded by non-activated, non-adhesive, hydrophobic areas.
Injection moulded article made from a composition comprising: 81-88wt% of a propylene homopolymer having a melt flow rate (measured under a load of 2.16 kg at 230°C according to ISO 1133) of between 1 and 2 g/10min; 12-19wt% of a propylene-ethylene copolymer containing 45 - 65wt% of ethylene; and 50 - 10000 ppm by weight of a nucleating agent, wherein the total ethylene content of the composition is 6-10wt%, and the melt flow rate of the composition is 0.7 - 2 g/10min. 81-88wt% of a propylene homopolymer having a melt flow rate (measured under a load of 2.16 kg at 230°C according to ISO 1133) of between 1 and 2 g/10min; 12-19wt% of a propylene-ethylene copolymer containing 45 - 65wt% of ethylene; and 50 - 10000 ppm by weight of a nucleating agent,
A method of measuring the deformation of a part in a turbine engine by means of a device comprising a rod (32, 66) having a portion (34, 68) with a profile that corresponds to the profile of a portion (17, 19) of a calibration part of the same type as the part under examination, said portion (34, 68) of the rod (32, 66) further including visible marks (40, 42) for remote measurement arranged along its length, characterized in that it consists: a) inspecting the profile of the rod (32, 66) in three dimensions with the help of a three-dimensional model of the profile of the portion of the calibration part; b) engaging the rod (32, 66) in an endoscope orifice in a casing of the engine; c) positioning and fastening the shaped portion (34, 68) of the rod (32, 66) on the portion of the part for inspection that corresponds to the portion of the calibration part; d) introducing an endoscope inside the casing of the engine; e) measuring the deformation of the portion of the part for inspection with the help of the endoscope, and then f) withdrawing the rod from the inside of the engine and performing a step a) once more in order to verify that the rod has not been subjected to deformation during step b). a) inspecting the profile of the rod (32, 66) in three dimensions with the help of a three-dimensional model of the profile of the portion of the calibration part; b) engaging the rod (32, 66) in an endoscope orifice in a casing of the engine; c) positioning and fastening the shaped portion (34, 68) of the rod (32, 66) on the portion of the part for inspection that corresponds to the portion of the calibration part; d) introducing an endoscope inside the casing of the engine; e) measuring the deformation of the portion of the part for inspection with the help of the endoscope, and then f) withdrawing the rod from the inside of the engine and performing a step a) once more in order to verify that the rod has not been subjected to deformation during step b).
A biological information measurement device comprising: a pressure sensor which includes a plurality of pressure detecting elements which are arranged in one direction; a pressing mechanism which is configured to press the pressure sensor against a wrist of a person to be measured, in a state where the one direction intersects with an elongation direction of a radial artery that is under a skin of the wrist; a biological information calculating section which is configured to calculate biological information based on information of pressure pulse waves which are detected by the pressure detecting elements in a state where the pressure sensor is pressed against the wrist by the pressing mechanism; and the device being characterized by: a personal identifying section which is configured to determine whether the person to be measured is a registered user who is previously registered or not, based on data indicating relationships between information of pressure signals which are detected by the pressure detecting elements of the pressure sensor in a pressed state where the pressure sensor is pressed against the wrist by the pressing mechanism, and positions of the pressure detecting elements in the one direction. a pressure sensor which includes a plurality of pressure detecting elements which are arranged in one direction; a pressing mechanism which is configured to press the pressure sensor against a wrist of a person to be measured, in a state where the one direction intersects with an elongation direction of a radial artery that is under a skin of the wrist; a biological information calculating section which is configured to calculate biological information based on information of pressure pulse waves which are detected by the pressure detecting elements in a state where the pressure sensor is pressed against the wrist by the pressing mechanism; and the device being characterized by: a personal identifying section which is configured to determine whether the person to be measured is a registered user who is previously registered or not, based on data indicating relationships between information of pressure signals which are detected by the pressure detecting elements of the pressure sensor in a pressed state where the pressure sensor is pressed against the wrist by the pressing mechanism, and positions of the pressure detecting elements in the one direction.
A method for interacting with a user wearing an augmented reality, AR, device, comprising: detecting (201, 202) by the AR device a movement pattern of the user that indicates that the user is in a first state; capturing (203, 204) by the AR device a low resolution frame of a field of view of the user in response to said detecting of the first state; determining (205, 206) from the low resolution frame an image target, wherein the image target has a linked AR content; alerting (207, 208) the user that the linked AR content for the image target is available; receiving (209, 210) by the AR device a command from the user on whether he wants to interact with the linked AR content; capturing (211, 214) by the AR device a full resolution frame of the field of view of the user if the command indicates the user wants to interact with the linked AR content; and displaying (213, 216) by the AR device the linked AR content to the user. detecting (201, 202) by the AR device a movement pattern of the user that indicates that the user is in a first state; capturing (203, 204) by the AR device a low resolution frame of a field of view of the user in response to said detecting of the first state; determining (205, 206) from the low resolution frame an image target, wherein the image target has a linked AR content; alerting (207, 208) the user that the linked AR content for the image target is available; receiving (209, 210) by the AR device a command from the user on whether he wants to interact with the linked AR content; capturing (211, 214) by the AR device a full resolution frame of the field of view of the user if the command indicates the user wants to interact with the linked AR content; and displaying (213, 216) by the AR device the linked AR content to the user.
A composition containing not less than 10% w/w of oroxylin A, not less than 10% w/w of baicalein and not less than 2% w/w of chrysin for use in the therapeutic management of chemotherapeutics-induced or hyperglycemia induced neurotoxicity in a mammal.
An in vitro method for monitoring the onset of liver damage after chemotherapy of colorectal cancer, wherein the liver damage comprises congestive liver due to destruction of sinusoidal cells, and wherein said method comprises measuring or monitoring the ADAMTS 13 activity in a sample from a mammal.
A data repeater (100, 30) comprising: a function recognition unit configured to recognize a function which the data repeater (100, 30) is to provide for received data as a communication path between one repeater management server and one of multiple repeaters, when a fixed specific port number assigned to the function as the communication path is identified in destination port information of data received from the repeater management server; and a controller configured to identify a source port number in source port information of the received data, and identify a specific IP address of one of the multiple repeaters which is mapped with the source port number, and transmit the data to the one of the multiple repeaters specified by the specific IP address, when the function is recognized as the communication path between the repeater management server and one of the multiple repeaters, wherein the controller is further configured to perform conversion between the specific IP address and the source port number in source port information of the received data on the basis of a mapping table in which for each of the multiple repeaters, a port number of the repeater management server as a source port number and an IP address of the respective multiple repeater are mapped. a function recognition unit configured to recognize a function which the data repeater (100, 30) is to provide for received data as a communication path between one repeater management server and one of multiple repeaters, when a fixed specific port number assigned to the function as the communication path is identified in destination port information of data received from the repeater management server; and a controller configured to identify a source port number in source port information of the received data, and identify a specific IP address of one of the multiple repeaters which is mapped with the source port number, and transmit the data to the one of the multiple repeaters specified by the specific IP address, when the function is recognized as the communication path between the repeater management server and one of the multiple repeaters, wherein the controller is further configured to perform conversion between the specific IP address and the source port number in source port information of the received data on the basis of a mapping table in which for each of the multiple repeaters, a port number of the repeater management server as a source port number and an IP address of the respective multiple repeater are mapped.
A foldable terminal apparatus, comprising a terminal body and a bendable touch screen, the bendable touch screen in a bending direction having a fixed end connected to the terminal body and a free end, and the bendable touch screen being switched between a first state and a second state, wherein in the first state, the bendable touch screen surrounds the terminal body on an outer side of the terminal body, and in the second state, the fixed end of the bendable touch screen is located on the terminal body and the free end is located outside the terminal body; further comprising a supporting frame, wherein in the first state, the supporting frame is accommodated between the outer side of the terminal body and the bendable touch screen, and in the second state, the supporting frame expands into a plane and is located at a bottom of the bendable touch screen to support the bendable touch screen expanded into a plane; wherein the supporting frame is a telescopic supporting frame having one end fixedly connected to the terminal body; characterized in that, the telescopic supporting frame comprises at least two connecting sections having radial dimensions decreasing or increasing progressively in a direction away from the terminal body in the second state, and every two adjacent connecting sections has matched inner and outer diameter dimensions; and the foldable terminal apparatus further comprises an inner and outer sliding gear set arranged between every two adjacent connecting sections of the telescopic supporting frame. further comprising a supporting frame, wherein in the first state, the supporting frame is accommodated between the outer side of the terminal body and the bendable touch screen, and in the second state, the supporting frame expands into a plane and is located at a bottom of the bendable touch screen to support the bendable touch screen expanded into a plane; wherein the supporting frame is a telescopic supporting frame having one end fixedly connected to the terminal body; characterized in that, the telescopic supporting frame comprises at least two connecting sections having radial dimensions decreasing or increasing progressively in a direction away from the terminal body in the second state, and every two adjacent connecting sections has matched inner and outer diameter dimensions; and the foldable terminal apparatus further comprises an inner and outer sliding gear set arranged between every two adjacent connecting sections of the telescopic supporting frame.
A cyclic hexapeptide comprising at least two alanine residues, comprising N-methylated residues at positions 1 and 6 and the sequence RGD wherein R is arginine residue (Arg), G is glycine residue (Gly), and D is aspartic acid (Asp) residue, wherein the cyclization is a head-to-tail cyclization.